Broadmark Realty Capital Inc. Stock News

Broadmark Realty Capital has seen its share price decline 60% year-to-date as the US residential real estate market has gone from hot to cold. Broadmark has many issues including: high level of non-pe

Prior to November 30, 2022, readers mentioned 43 equities in their recent comments. Some lamented bad-news, so bad-news investments (rogues) mixed with (mostly) favorites. (Thus, these are ReFa/Ro.).

REITs are historically cheap due to misplaced fears. Read more to see two such REIT picks that we are buying.

Analysts have provided the following ratings for Broadmark Realty Capital (NYSE:BRMK) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 1

I am very bullish on most REITs at today's prices, but not on all of them. Find out 2 REIT stocks that we've sold.

I am very bullish on most REITs at today's prices. But not on all of them.

Since our last report, Broadmark Realty Capital Inc.'s conditions have gone from bad to worse. Broadmark posted Q3 results with earnings misses on the top and bottom lines. Broadmark Realty results th

REIT sector is extremely volatile these days. It resulted in some opportunities for us to consolidate capital. We highlight 3 REITs/REIT-like entities that we sold recently. Read more here.

The REIT sector is extremely volatile these days. It has resulted in some opportunities for us to consolidate capital.

Broadmark Realty moved down by over 13% on the back of a fiscal 2022 third quarter that saw a miss on both revenue and earnings. The CFO and CEO have both departed the company in the space of one mont

Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday. TaskUs, Inc. (NAS

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast ca

Gainers Ocuphire Pharma, Inc. (NASDAQ: OCUP) shares rose 27.8% to $2.67 in pre-market trading. Ocuphire Pharma entered into a global license agreement for development and commercialization of Nyxol

Broadmark Realty (BRMK) delivered earnings and revenue surprises of -25% and 9.40%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Broadmark Realty Capital Inc. (NYSE:BRMK ) Q3 2022 Earnings Conference Call November 7, 2022 5:00 PM ET Company Participants Nevin Boparai – General Counsel Jeffrey Pyatt – Interim Chief Executive